- Home
- NINE vs GDTC Comparison
NINE vs GDTC Comparison
Compare NINE & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NINE
- GDTC
- Stock Information
- Founded
- NINE 2011
- GDTC 2018
- Country
- NINE United States
- GDTC Singapore
- Employees
- NINE N/A
- GDTC N/A
- Industry
- NINE Oilfield Services/Equipment
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- NINE Energy
- GDTC Health Care
- Exchange
- NINE Nasdaq
- GDTC Nasdaq
- Market Cap
- NINE 38.9M
- GDTC 33.4M
- IPO Year
- NINE 2018
- GDTC 2023
- Fundamental
- Price
- NINE $1.00
- GDTC $2.56
- Analyst Decision
- NINE
- GDTC Buy
- Analyst Count
- NINE 0
- GDTC 1
- Target Price
- NINE N/A
- GDTC $5.00
- AVG Volume (30 Days)
- NINE 1.2M
- GDTC 26.6K
- Earning Date
- NINE 10-31-2024
- GDTC 01-01-0001
- Dividend Yield
- NINE N/A
- GDTC N/A
- EPS Growth
- NINE N/A
- GDTC N/A
- EPS
- NINE N/A
- GDTC N/A
- Revenue
- NINE $556,751,000.00
- GDTC $330,254.00
- Revenue This Year
- NINE N/A
- GDTC $14.71
- Revenue Next Year
- NINE $2.93
- GDTC N/A
- P/E Ratio
- NINE N/A
- GDTC N/A
- Revenue Growth
- NINE N/A
- GDTC N/A
- 52 Week Low
- NINE $0.75
- GDTC $1.20
- 52 Week High
- NINE $3.26
- GDTC $5.50
- Technical
- Relative Strength Index (RSI)
- NINE 39.45
- GDTC 51.57
- Support Level
- NINE $0.96
- GDTC $2.26
- Resistance Level
- NINE $1.87
- GDTC $3.00
- Average True Range (ATR)
- NINE 0.13
- GDTC 0.41
- MACD
- NINE -0.06
- GDTC -0.04
- Stochastic Oscillator
- NINE 12.64
- GDTC 27.85
About NINE Nine Energy Service Inc.
Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.